What is CYRX's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.88B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for CYRX?

P/E (TTM) is n/a and 52-week range is $7.61 to $18.36 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s CYRX figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for CYRX?

The company profile lists revenue (TTM) near $186M, net income (TTM) near $-3.74B, EPS (TTM) near $-0.75 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Cryoport Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Brentwood, Tennessee, US, 50.4M shares outstanding, ISIN US2290503075 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

Cryoport Inc

$CYRX

Health Care · Life Sciences Tools & Services

IR Run Scenarios

$17.35

+2.66%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. The company is headquartered in Brentwood, Tennessee and currently employs 684 full-time employees. The company went IPO on 2015-07-24. The firm operates through two segments: segments: Life Sciences Services and Life Sciences Products. Its life sciences services include BioLogistics and BioStorage/BioServices, which provides temperature-controlled logistics, biostorage and bioservices within the life science industry through direct sales. Its life sciences products segment manufactures and sells cryogenic systems, such as freezers and cryogenic dewars and related ancillary accessories used in the storage and transport of life science commodities through direct sales or a distribution network. Its operating units include Cryoport Systems, CryoGene and MVE Biological Solutions (MVE). Cryoport Systems provides temperature-controlled BioLogistics, BioServices, and cryopreservation solutions, supporting clinical and commercial workflows through transport, kit production, labeling, packaging, and others.

Employees

688

Website

www.cryoport.com/

IPO

2015-07-24

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)